Drug Shortage Report for TEVA-MOMETASONE
| Report ID | 160445 |
| Drug Identification Number | 02475863 |
| Brand name | TEVA-MOMETASONE |
| Common or Proper name | MOMETASONE FURO SPRAY 50MCG |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | MOMETASONE FUROATE |
| Strength(s) | 50MCG |
| Dosage form(s) | SPRAY, METERED DOSE |
| Route of administration | NASAL NASAL |
| Packaging size | 18gm |
| ATC code | R01AD |
| ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2022-05-10 |
| Estimated end date | 2022-09-20 |
| Actual end date | 2022-09-07 |
| Shortage status | Resolved |
| Updated date | 2022-09-08 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2022-09-08 | English | Compare |
| v8 | 2022-09-07 | French | Compare |
| v7 | 2022-09-07 | English | Compare |
| v6 | 2022-08-18 | French | Compare |
| v5 | 2022-08-18 | English | Compare |
| v4 | 2022-06-30 | French | Compare |
| v3 | 2022-06-30 | English | Compare |
| v2 | 2022-05-12 | French | Compare |
| v1 | 2022-05-12 | English | Compare |
Showing 1 to 9 of 9